Navigation Links
Enbrel(R) (etanercept) Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting
Date:10/16/2009

ess or failure of our products or product candidates. Further, the discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations.

The scientific information discussed in this news release relating to new indications for our products is preliminary and investigative and is not part of the labeling approved by the U.S. Food and Drug Administration (FDA) for the products. The products are not approved for the investigational use(s) discussed in this news release, and no conclusions can or should be drawn regarding the safety or effectiveness of the products for these uses. Only the FDA can determine whether the products are safe and effective for these uses. Healthcare professionals should refer to and rely upon the FDA-approved labeling for the products, and not the information discussed in this news release.

    CONTACT:
    Amgen
    Sonia Fiorenza, 805-447-1604 (media)
    Arvind Sood, 805-447-1060 (investors)

    Pfizer
    Danielle Halstrom, 484-865-2020 (media)
    Claire Ball, 973-660-6411 (investors)

(Logo: http://www.newscom.com/cgi-bin/prnh/20081023/ENBRELLOGO)

SOURCE Amgen


'/>"/>
SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Enbrel(R) (etanercept) Is the First Biologic With Published Efficacy and Safety Data for up to a Decade of Continuous Use for the Treatment of Moderate to Severe Rheumatoid Arthritis
2. Plastic Surgery 2009 News Briefs - Selected Research to be Presented on Tuesday, October 27
3. Plastic Surgery 2009 News Briefs - Selected Research to be Presented on Monday, October 26
4. Plastic Surgery 2009 News Briefs - Select Research to be Presented on Sunday, October 25
5. Plastic Surgery 2009 News Briefs -- Research To Be Presented on Saturday, October 24
6. Novel Information about Vulnerable Coronary Artery Plaque to be Presented at Transcatheter Cardiovascular Therapeutics (TCT) 2009
7. PolyOne Presented with Frost & Sullivan Medical Product Award
8. CRF announces featured clinical trials to be presented at TCT 2009 in San Francisco
9. Kuvan and Naglazyme Data to Be Presented at the 11th Annual ICIEM Meeting
10. Centers of Excellence Awards Presented to Over 100 Nursing Facilities as Nursing Facilities Reach the Tipping Point in Treating Pressure Ulcers
11. CRF announces late breaking trials to be presented at TCT 2009 in San Francisco
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... 27, 2015 Ticket Down is a reputable ... "Forest Hills Drive Tour Act 3: Hollywood" Tour. This tour ... Drive" which debuted on the charts at #1 and went ... March, this accomplished hip-hop artist will begin touring in conjunction ... will visit cities such as San Antonio, New Orleans, Tallahassee, ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Transfinder is ... one of the Best Companies to Work for in ... the importance of creating a great work environment. People ... yet professionally fulfilling – environment. There’s no reason why ... together,” said Antonio Civitella, president and CEO of Transfinder, ...
(Date:2/27/2015)... 2015 Cocaine is an extreme stimulant, ... depression and hostility. In a joint effort between Australian ... of cocaine, may soon rejoice in what has been ... addictive biological response of cocaine, according to 7 ... researchers discovered that the brain is continually communicating with ...
(Date:2/27/2015)... 2015 Local lice removal service reports that ... the areas of Pinecrest, Key Biscayne, Coral Gables, Miami Beach ... they attempt to isolate and eradicate the problem. , ... photograph may be partly to blame. As kids put their ... head-to-head contact that can allow for the spread of head ...
(Date:2/27/2015)... CA (PRWEB) February 27, 2015 RDI-Engineering ... Your Mind: Pi Day event on March 14, at ... RDI-Engineering’s services, demonstrations on how to use engineering software ... event will be hosted by Moreno Valley College’s Upward ... Student Success Center (SSC) in hopes to encourage students ...
Breaking Medicine News(10 mins):Health News:J. Cole Tickets in Los Angeles, Mountain View, Chula Vista, New York, Chicago, Indianapolis, Holmdel, Dallas, Seattle, Camden, Bristow, Atlanta, Houston & Detroit On Sale 2Health News:J. Cole Tickets in Los Angeles, Mountain View, Chula Vista, New York, Chicago, Indianapolis, Holmdel, Dallas, Seattle, Camden, Bristow, Atlanta, Houston & Detroit On Sale 3Health News:Transfinder Named a Best Company to Work for in New York State 2Health News:A New Study May Have an Answer to Treating Cocaine Addiction 2Health News:A New Study May Have an Answer to Treating Cocaine Addiction 3Health News:Parents frustrated as selfies continue to contribute to the spread of head lice in Miami according to the largest Lice Removal Service in Miami called Lice Troopers 2Health News:RDI-Engineering Participates in STEM”U”LATE Your Mind Event to Host Educational Exhibition 2
... ... WHO: Valley Forge Medical Center ... ... 2 Valley Forge Medical Center and,Hospital is the first facility on the East Coast to ...
... June 2 BeaconEquity.com announces the,availability of TraderNotes on ... view all of the daily trading notes for free ... Inc. (OTC Bulletin Board: TPIM),RXi Pharmaceuticals Corp. (Nasdaq: ... Inc. (Amex: CUR ), Amgen Inc. (Nasdaq: ...
... pancreatic cancer with a combination of chemotherapy, biotherapy and ... beneficial for patients, according to a University of Pittsburgh ... meeting of the American Society of Clinical Oncology (ASCO) ... the Pancreatic Cancer Center of the University of Pittsburgh ...
... link was most pronounced for low-birth-weight girls , , MONDAY, June ... early have more than double the risk of developing autism, ... low-birth-weight girls, said the authors of the study, which was ... , The study, by researchers at the U.S. Centers for ...
... 2, 2008 Results from an analysis assessing the ... among employees suffering from multiple sclerosis (MS) being treated ... announced by Biogen Idec as poster presentations at the ... Denver, Colorado, May 28-May 31, 2008. The results revealed ...
... June 2 Angioslide, Ltd. today,announced the closing ... is the developer of the unique Angioslide eXtra(TM) ... single device,offering balloon angioplasty with embolic protection. The ... limb use and FDA clearance is,expected by end ...
Cached Medicine News:Health News:Valley Forge Medical Center and Hospital to Become the First Addiction-Free Pain Management Center of Excellence on the East Coast; Will Host Three Day Professional Training Seminar. 2Health News:Valley Forge Medical Center and Hospital to Become the First Addiction-Free Pain Management Center of Excellence on the East Coast; Will Host Three Day Professional Training Seminar. 3Health News:BeaconEquity.com Issues TraderNotes on Biotechnology Stocks: TPIM, RXII, VION, CUR, AMGN, GILD, BIIB, GENR 2Health News:BeaconEquity.com Issues TraderNotes on Biotechnology Stocks: TPIM, RXII, VION, CUR, AMGN, GILD, BIIB, GENR 3Health News:New treatment combination safe for pancreatic cancer patients 2Health News:Being Born Small, Early Raises Autism Risk 2Health News:Being Born Small, Early Raises Autism Risk 3Health News:New data show patients using avonex reported less sick leave and short-term disability costs 2Health News:Angioslide Closes US$8.6million Series C Financing 2
(Date:2/27/2015)... CARLSBAD, Calif., Feb. 27, 2015 Isis Pharmaceuticals, ... significantly outperformed both its pro forma net operating loss ... in a strong financial position.  Isis, significantly improved financial ... than $230 million in payments the Company received from ... for 2014 was a nearly 60% improvement over its ...
(Date:2/27/2015)... -- Report Details   Translational ... progress, and predicted revenues ,Where is the market for ... prospects for this market and related technologies? Visiongain,s brand ... to 2025, discussing data, opportunities and prospects. ... medicine : cell-based therapies that aim to restore function ...
(Date:2/27/2015)... PLAINFIELD, N.J., Feb. 27, 2015  PTC Therapeutics, Inc. ... update and reported financial results for the fourth quarter ... "2014 was a transformative year for PTC. We ... delivering and developing RNA-targeted therapies in the rare disease ... PTC Therapeutics, Inc. "We are proud to bring the ...
Breaking Medicine Technology:Isis Reports Financial Results and Highlights for 2014 2Isis Reports Financial Results and Highlights for 2014 3Isis Reports Financial Results and Highlights for 2014 4Isis Reports Financial Results and Highlights for 2014 5Isis Reports Financial Results and Highlights for 2014 6Isis Reports Financial Results and Highlights for 2014 7Isis Reports Financial Results and Highlights for 2014 8Isis Reports Financial Results and Highlights for 2014 9Isis Reports Financial Results and Highlights for 2014 10Isis Reports Financial Results and Highlights for 2014 11Isis Reports Financial Results and Highlights for 2014 12Isis Reports Financial Results and Highlights for 2014 13Isis Reports Financial Results and Highlights for 2014 14Isis Reports Financial Results and Highlights for 2014 15Isis Reports Financial Results and Highlights for 2014 16Isis Reports Financial Results and Highlights for 2014 17Translational Regenerative Medicine: Market Prospects 2015-2025 2Translational Regenerative Medicine: Market Prospects 2015-2025 3Translational Regenerative Medicine: Market Prospects 2015-2025 4Translational Regenerative Medicine: Market Prospects 2015-2025 5Translational Regenerative Medicine: Market Prospects 2015-2025 6Translational Regenerative Medicine: Market Prospects 2015-2025 7Translational Regenerative Medicine: Market Prospects 2015-2025 8PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 10PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 11
... A unique treatment involving the use of hot chemotherapy ... Center. SJH&MC is the first hospital in Southeast Michigan ... offer the treatment. Know as Hyperthermic Intraperitoneal ... number of advanced cancers that have spread to the ...
... and SYDNEY, Nov. 4, 2011 HeartWare International, Inc. ... leading innovator of less invasive, miniaturized circulatory support technologies ... today announced that CEO Doug Godshall is scheduled to ... 11:00 a.m. MST on Wednesday, November 9, 2011.  The ...
Cached Medicine Technology:St. John Hospital 1st in Region to Offer Innovative Chemotherapy Delivery System 2HeartWare to Present at the Credit Suisse 2011 Healthcare Conference 2
... ergonomic chairs with concave seats and large ... like seats, backrests, armrests, and casters and ... top performance in a variety of environments ... control, health care and office. • With ...
... Durable ergonomic chairs with concave ... support • Select options like seats, ... • Choose the BE Series for ... environments including: industry, education, laboratory, clean ...
... chairs with concave seats and large ... options like seats, backrests, armrests, and ... BE Series for top performance in ... education, laboratory, clean room, static control, ...
... concave seats and large backrests with lumbar ... armrests, and casters and glides. • Choose ... a variety of environments including: industry, education, ... and office. • With tubular base • ...
Medicine Products: